Medpace Holdings (MEDP) Cash from Investing Activities Growth (3y) (2018 - 2026)
Medpace Holdings (MEDP) Cash from Investing Activities Growth (3y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,010.71 Bn | 30,010.25 Bn | 1.11 Bn | - |
| 2 | Thermo Fisher Scientific | 179.46 Bn | 176.21 Bn | 7.74 Bn | -41.81% |
| 3 | Danaher | 130.33 Bn | 124.64 Bn | 3.59 Bn | 5.49% |
| 4 | Idexx Laboratories | 44.44 Bn | 44.24 Bn | 722.74 Mn | 5.31% |
| 5 | Agilent Technologies | 37.27 Bn | 35.46 Bn | 990.00 Mn | 0.00% |
| 6 | Iqvia Holdings | 30.70 Bn | 28.73 Bn | 1.36 Bn | 4.07% |
| 7 | Natera | 30.59 Bn | 29.49 Bn | 696.04 Mn | -59.07% |
| 8 | Illumina | 24.86 Bn | 23.71 Bn | 721.00 Mn | -86.97% |
| 9 | Mettler Toledo International | 23.06 Bn | 23.00 Bn | 555.82 Mn | -11.88% |
| 10 | Medpace Holdings | 13.30 Bn | 12.64 Bn | 196.33 Mn | 10.78% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.78% |
| Dec 31, 2025 | 21.42% |
| Sep 30, 2025 | -14.04% |
| Jun 30, 2025 | 18.52% |
| Mar 31, 2025 | 3.77% |
| Dec 31, 2024 | 6.04% |
| Sep 30, 2024 | -16.69% |
| Jun 30, 2024 | -28.72% |
| Mar 31, 2024 | 31.27% |
| Dec 31, 2023 | -1.12% |
| Sep 30, 2023 | -0.07% |
| Jun 30, 2023 | 3.13% |
| Mar 31, 2023 | -19.84% |
| Dec 31, 2022 | -17.18% |
| Sep 30, 2022 | -5.43% |
| Jun 30, 2022 | -47.89% |
| Mar 31, 2022 | -42.89% |
| Dec 31, 2021 | -29.35% |
| Sep 30, 2021 | -33.24% |
| Jun 30, 2021 | 0.25% |